albendazole; hydroxypropyl-beta-cyclodextrin; oral solution; bioavailability; veterinary dosage forms
Abstract :
[en] Albendazole (ABZ) is a benzimidazole derivative with a broad spectrum of activity against human and animal helminthe parasites. ABZ has a very poor aqueous solubility. This study shows that hydroxypropyl-beta-cyclodextrin (HP-beta-CD) is able to form inclusion complexes with ABZ and that is able to increase its aqueous solubility. A synergistic effect exists between HP-beta-CD and citric acid. The combination of HP-beta-CD (200 mM) and citric acid (50 mM) allows dissolution of more than 1.5 mg of ABZ per ml. The aim of this study is the in vivo evaluation in sheep of a solution of the inclusion complex of ABZ with HP-beta-CD in comparison with a suspension of the same drug. A significant (P<0.05) increase in the relative bioavailability is obtained with the solution containing the ABZ-HP-beta-CD complex as measured by ABZSO plasma levels. The area under the curve (AUC(0--> proportional, variant )) of the solution is 37% higher than that obtained with the suspension. Likewise the peak plasma concentration (C(max)) is twice that of the solution while the time to reach C(max) (T(max)) is reduced.
Disciplines :
Chemistry Pharmacy, pharmacology & toxicology
Author, co-author :
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Chiap, Patrice ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
De Tullio, Pascal ; Université de Liège - ULiège > Chimie pharmaceutique
Ghalmi, F.
Piel, Géraldine ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique et magistrale
Van Hees, Thierry ; Université de Liège - ULiège > Département de pharmacie > Pharmacie clinique
Crommen, Jacques ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Losson, Bertrand ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires > Parasitologie et pathologie des maladies parasitaires
Delattre, Luc ; Université de Liège - ULiège > Département de pharmacie > Département de pharmacie
Language :
English
Title :
Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin
Cook G.C. Use of benzimidazole chemotherapy in human helminthiases: Indications and efficacy. Parasitol. Today. 6:1990;133-136.
Wen H., New R.R.C., Craig P.S. Diagnosis and treatment of human hydatidosis. Br. J. Clin. Pharm. 35:1993;565-574.
Del-Brutto Sotelo O.H., Roman G.C. Therapy for neurocysticercosis: a reappraisal. Clin. Infect. Dis. 17:1993;730-735.
Gil-Grande A.L., Rodrigez-Caabeiro F., Prieto J.G., Sanchez-Ruano J.J., Brasa C., Aguilar L., Garcia-hoz F., Casado N., Barcena R., Alvarez A.I. Randomised controlled trial of efficacy of albendazole in intraabdominal hydatic disease. Lancet. 342:1993;1269-1272.
Van-Nieuwkerk K.M., Veenstra J., Wassenaar R.P., Blaauwgeers H.L., Geraedts A.A., Kroes H. Pancreatis caused by rupture of hydatid liver cyst. Eur. J. Gastroenterol. Hepatol. 5:1993;563-565.
Yasawy M.I., Al-Karawi M.A., Are M. Combination of praziquantel and albendazol in the treatment of hydatic disease. Trop. Med. Parasitol. 44:1993;192-194.
Torrado S., Torrado S., Torrado J.J., Cardoniga R. Preparation, dissolution and characterization of albendazole solid dispersions. Int. J. Pharm. 140:1996;247-250.
Torrado S., Torrado S., Cardoniga R., Torrado J.J. Formulation parameters of albendazole solution. Int. J. Pharm. 140:1996;45-50.
Del Estal J.L., Alvarez A.I., Villaverde C., Prieto J.G. Comparative effects of anionic, natural bile acid surfactants and mixed micelles on the intestinal absorption of the anthelmintic albendazole. Int. J. Pharm. 91:1993;105-109.
Wen H., New R.R., Muhmut M., Wang Y.H., Zang J.H., Shao Y.M., Craig P.S. Pharmacology and efficacy of liposome entrapped albendazole in exprimental secondary alveolar echinococcosis and effect of co-administration with cimetidine. Parasitology. 113:(Pt2):1996;111-121.
Kata M., Shauer M. Increasing the solubility characteristics of albendazole with dimethyl-β-cyclodextrin. Acta Pharm. Hung. 61:1991;23-31.
Bassani V.L., Krieger D., Duchene D., Wouessidjewe D. Enhanced water solubility of albendazole by hydroxypropyl-β-cyclodextrin complexation. Szejtli J., Szente L. Proceedings of the Eighth International Symposium on Cyclodextrins. 1996;321-324 Kluwer Academic Publishers.
Piel G., Evrard B., Van Hees T., Llabres G., Delattre L. Development of a parenteral and an oral formulation of albendazole with cyclodextrins. Stp Pharma. Sci. 9:(3):1999;257-260.
Brewster M.E., Estes K.S., Bodor N. An intravenous toxicity study of hydroxypropyl-β-cyclodextrin, a useful drug solubilizer, in rats and in monkeys. Int. J. Pharm. 59:1990;231-243.
Benchaoui H.A., Futter I.J., Holton L.L., Genttinby G., McKellar Q.A. Bioavailability of different benzimidazole volume-dose formulations in sheep. Vet. Rec. 137:(7):1995;171-172.
Chiap P., Evrard B., Bimazubute M.A., De Tullio P., Hubert P., Delattre L., Crommen J. Liquid chromatographic determination of albendazole and its main metabolites in ovine plasma with dialysis as integrated sample preparation technique. J. Chromatogr. A. 870:2000;121-134.
Frömming K.H., Szejtli J. Cyclodextrins in Pharmacy. 1994;Kluwer Academic Publishers, The Netherlands.
P. Ventura, P. Chiesi, M. Pasini, E. Redenti, J. Szejtli, M. Vikmon, Highly soluble multicomponent inclusion complexes containing a base-type drug, an acid and a CD, US Patent 19950418519 D 1995 1115.
Gerlocky A., Szeman J., Csabai K., Kolbe I., Jicsinszky L., Acerbi D., Ventura P., Redenti E., Szejtli J. Pharmacokinetic study of orally administered ketoconazole and its multicomponent complex on rabbits of normal and low gastric acidity. Szejtli J., Szente L. Proceedings of the Eighth International Symposium on Cyclodextrins. 1996;515-518 Kluwer Academic Publishers.
Piel G., Evrard B., Fillet M., Llabres G., Delattre L. Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. Int. J. Pharm. 169:1998;15-22.
Torrado S., Lopez M.L., Torrado G., Bolas F., Torrado S., Cadorniga R. A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation. Int. J. Pharm. 156:1997;181-187.
Galtier P., Alvinerie M., Steimer J.L., Francheteau P., Plusquellec Y., Houin G. Simultaneous pharmacokinetic modeling of a drug and two metabolites: application to albendazole in sheep. J. Pharm. Sci. 80:(1):1991;3-10.
McKellar Q.A., Scott E.W. The benzimidazole anthelminic agent. A rewiew. J. Vet. Pharmacol. Therap. 13:1990;223-247.
Prieto J.G., Justel A., del Estal J.L., Barrio J.P., Alvarez A.I. Comparative study on gastric absorption of albendazole and mebendazole in rats. Comp. Biochem. Physiol. 100C:1991;397-400.
Lanusse C.E., Gascon L.H., Prichard R.K. Comparative plasma disposition kinetics of albendazole, fenbendazole, oxfenbendazole and their metabolites in adult sheep. J. Vet. Pharmacol. Therap. 18:1995;196-203.
Hennessy D.R., Sangster N.C., Steel J.W., Collins G.H. Comparative pharmacokinetic behaviour of albendazole in sheep and goats. Int. J. Parasitol. 23:(3):1993;321-325.
Sanchez S.F., Alvarez L.I., Lanusse C.E. Fasting-induced changes to the pharmacokinetic behaviour of albendazole and its metabolites in calves. J. Vet. Pharmacol. Therap. 20:1997;38-47.
Kwan L.C., Gyurik R.J., Freeman J.F., Chimes N., Ritch G.M., Theodorides V.J. Influence of dosing regimens on the anthelmintic activity of albendazole in sheep. J. Controlled Release. 8:1988;31-38.